 Over the last 15 years these practices have gradually become embedded in clinical practice and real‐world data has observed corresponding improvements in patient survival (Abrahamsson et al, 2014; Leux et al, 2014).The overall 5-year survival rate for MCL is generally 50% (advanced stage MCL) to 70% (for limited-stage MCL).Prognosis for individuals with MCL is problematic and indexes do not work as well due to patients presenting with advanced stage disease.